The on-chip NAFLD model mimicked the characteristics of NAFLD <i>in vivo</i>, including intracellular lipid accumulation and impaired hepatocyte functions in albumin synthesis, levels of urea, CYP1A2, and CYP3A4. Here, CYP1A2 is linked to metabolic dysfunction-associated steatotic liver disease.